SHP-610

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSHP-610

Drug Alias NameRecombinant human heparan N-sulfataserhHNSHGT-1410SHP-610

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionHeparan sulfate sulfatase replacements

TargetsHeparan sulfate

Therapy Area/IndicationsMucopolysaccharidosis IIIMucopolysaccharidoses

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesNetherlandsItaly +[8]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesShire

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesShire

Active IndicationsN/A

Inactive IndicationsMucopolysaccharidosis IIIMucopolysaccharidoses

ATC CodeN/A